Cancel
See Linkedin
Known information
- Spent more than 25 years leading services and therapeutic companies in the Life Sciences sector
- Started his career in EY's consulting practice
- Spent nearly 10 years running major accounts and practice areas for EY
- Served on the executive team at Valeant (now Bausch Health) for nearly five years, first as CIO and then running the company's Asia business
- Was recruited to help lead the turn-around of Patheon
- During his seven-year tenure at Patheon, had leadership of key functions including Strategy, Corporate Development, Sales, Marketing, Pricing and Contracting, and concluded his tenure as the President of the Banner Life Sciences division
- Served as the CEO of Sancilio Pharmaceuticals
- Worked with many Private Equity groups, including as an Operating Partner at LongueVue Capital
- Currently serves as the Chairman of Avadel Pharmaceuticals (NASDAQ: AVDL)
About KINICITI
KINICITI invests in non-therapeutic companies enhancing cell and gene therapy innovation, providing them with capital, expertise, and strategic resources to accelerate their growth and impact.
Report inaccurate information